Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 10401 - 10408 of 12127 results

Can A Relator Be Held Liable For Using Confidential Company Documents To Support A Qui Tam Case?

June 26, 2014| Blog| Viewpoint

D'oh! OCR Confirms that Medical Records Should Not be Left in the Driveway

June 26, 2014| Blog| Viewpoint

To our US Readers: Your Privacy & Security Matters Blog Public Service for Thursday, June 26

June 26, 2014| Blog| Viewpoint

A Tale of Two Jurisdictions: Human Rights Laws in New York City and Tennessee Head in Opposite Directions

June 25, 2014| Blog| Viewpoint

OCR Confirms that Medical Records Should Not be Left in the Driveway

June 25, 2014| Blog| Viewpoint

ML Strategies Posts Weekly Health Care Update on June 23, 2014

June 25, 2014| Blog| Viewpoint

A Committee of Fund Manager Personnel May Not Be Able to Provide the Requisite Consent on Behalf of the Fund for a Principal Transaction

June 25, 2014| Blog| Viewpoint

Massachusetts High Court Permits Compelled Decryption of Seized Digital Evidence

June 25, 2014| Blog| Viewpoint

News & Press Releases

Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering

September 12, 2025

Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”

Mintz Advises Premier Wealth Advisor Breed’s Hill Capital on Acquisition by Corient

September 12, 2025

Mintz represented Breed’s Hill Capital, a multi-family office overseeing approximately $3.5 billion in assets, in its acquisition by Corient, one of the nation’s leading wealth management firms. The transaction enhances Corient’s footprint in New England and advances its ability to deliver personalized fiduciary wealth management services across the region.

Three Mintz Attorneys Recognized in Lawdragon’s 2025 500 Leading Global Real Estate Lawyers

September 11, 2025

Mintz members Daniel Guggenheim, Rebecca Lee, and Jeffrey Moerdler have been recognized by Lawdragon in its 2025 500 Leading Global Real Estate Lawyers list. The three attorneys were also recognized in last year’s inaugural edition of the list.

View all News and Press Releases